MakCHS Publications

Found 341 results
Author [ Keyword(Desc)] Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Meningitis, Cryptococcal
B. Castelnuovo, Manabe, Y. C., Kiragga, A., Kamya, M., Easterbrook, P., and Kambugu, A., Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 49, no. 6, pp. 965-72, 2009.
Middle Aged
B. Castelnuovo, Byakwaga, H., Menten, J., Schaefer, P., Kamya, M., and Colebunders, R., Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?, AIDS (London, England), vol. 22, no. 2, pp. 269-73, 2008.
G. Kigozi, Gray, R. H., Wawer, M. J., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chen, M. Z., Sewankambo, N. K., Wabwire-Mangen, F., Bacon, M. C., Ridzon, R., Opendi, P., Sempijja, V., Settuba, A., Buwembo, D., Kiggundu, V., Anyokorit, M., Nkale, J., Kighoma, N., and Charvat, B., The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda., PLoS medicine, vol. 5, no. 6, p. e116, 2008.
B. Castelnuovo, Byakwaga, H., Menten, J., Schaefer, P., Kamya, M., and Colebunders, R., Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?, AIDS (London, England), vol. 22, no. 2, pp. 269-73, 2008.
R. H. Gray, Kiwanuka, N., Quinn, T. C., Sewankambo, N. K., Serwadda, D., Mangen, F. W., Lutalo, T., Nalugoda, F., Kelly, R., Meehan, M., Chen, M. Z., Li, C., and Wawer, M. J., Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team., AIDS (London, England), vol. 14, no. 15, pp. 2371-81, 2000.
B. Castelnuovo, Nanyonjo, A., Kamya, M., and Ocama, P., Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?, African health sciences, vol. 8, no. 2, pp. 133-4, 2008.
M. A. Eller, Blom, K. G., Gonzalez, V. D., Eller, L. A., Naluyima, P., Laeyendecker, O., Quinn, T. C., Kiwanuka, N., Serwadda, D., Sewankambo, N. K., Tasseneetrithep, B., Wawer, M. J., Gray, R. H., Marovich, M. A., Michael, N. L., de Souza, M. S., Wabwire-Mangen, F., Robb, M. L., Currier, J. R., and Sandberg, J. K., Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans., PloS one, vol. 6, no. 4, p. e18779, 2011.
D. Serwadda, Gray, R. H., Sewankambo, N. K., Wabwire-Mangen, F., Chen, M. Z., Quinn, T. C., Lutalo, T., Kiwanuka, N., Kigozi, G., Nalugoda, F., Meehan, M. P., Ashley Morrow, R., and Wawer, M. J., Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda., The Journal of infectious diseases, vol. 188, no. 10, pp. 1492-7, 2003.
G. Kigozi, Gray, R. H., Wawer, M. J., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chen, M. Z., Sewankambo, N. K., Wabwire-Mangen, F., Bacon, M. C., Ridzon, R., Opendi, P., Sempijja, V., Settuba, A., Buwembo, D., Kiggundu, V., Anyokorit, M., Nkale, J., Kighoma, N., and Charvat, B., The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda., PLoS medicine, vol. 5, no. 6, p. e116, 2008.
Pregnancy
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
J. Kagaayi, Dreyfuss, M. L., Kigozi, G., Chen, M. Z., Wabwire-Mangen, F., Serwadda, D., Wawer, M. J., Sewankambo, N. K., Nalugoda, F., Kiwanuka, N., Kiddugavu, M., and Gray, R. H., Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda., Journal of acquired immune deficiency syndromes (1999), vol. 39, no. 1, pp. 121-4, 2005.
Pregnancy Complications, Infectious
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
J. Kagaayi, Dreyfuss, M. L., Kigozi, G., Chen, M. Z., Wabwire-Mangen, F., Serwadda, D., Wawer, M. J., Sewankambo, N. K., Nalugoda, F., Kiwanuka, N., Kiddugavu, M., and Gray, R. H., Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda., Journal of acquired immune deficiency syndromes (1999), vol. 39, no. 1, pp. 121-4, 2005.
Proportional Hazards Models
B. Castelnuovo, Manabe, Y. C., Kiragga, A., Kamya, M., Easterbrook, P., and Kambugu, A., Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 49, no. 6, pp. 965-72, 2009.
Research Personnel
Y. C. Manabe, Jacob, S. T., Thomas, D., Quinn, T. C., Ronald, A., Coutinho, A., Mayanja-Kizza, H., and Merry, C., Resurrecting the triple threat: academic social responsibility in the context of global health research., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 48, no. 10, pp. 1420-2, 2009.
Social Responsibility
Y. C. Manabe, Jacob, S. T., Thomas, D., Quinn, T. C., Ronald, A., Coutinho, A., Mayanja-Kizza, H., and Merry, C., Resurrecting the triple threat: academic social responsibility in the context of global health research., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 48, no. 10, pp. 1420-2, 2009.

Pages